As Fierce Pharma points out, patent expirations are a routine occurrence in the pharmaceutical world, but 2025 stands out for ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

Auburn football kicker Alex McPherson was sidelined for much of 2024 with ongoing health issues. On Wednesday, he discussed ...

The 2024 season could best be described as one of hardship and frustration for Auburn kicker Alex McPherson. He made just one appearance all year due to a lingering gastrointestinal illness, which was ...

The drug-funding agency estimated that 1200 patients would benefit this year, rising to more than 5000 annually after 2030.

More New Zealanders will have access to medicines for blood cancers, bowel diseases, eczema and arthritis, following Pharmac’s decision to widen access to four medicines for six health conditions from ...

Discover AbbVie's strong performance, with immunology growth and undervaluation despite challenges. Click here to read an ...

Associate Health Minister with responsibility for Pharmac David Seymour, and Health Minister Simeon Brown welcome Pharmac's decision to widen access ...

Biosimilars Council’s Craig Burton predicted that only 10% of the drugs coming off patent soon will have competition.

Associate Health Minister with responsibility for Pharmac David Seymour, and Health Minister Simeon Brown welcome Pharmac’s ...

Patients with LVV and IBD present with distinct clinical characteristics, including earlier onset and more severe vascular involvement.

Sustained positive preliminary data from all completed single ascending dose (SAD) cohorts, multiple ascending dose (MAD) cohorts, and food ...